PromoCell GmbH, a Germany-based global manufacturer of primary human cells and specialised cell culture media for biomedical research, has entered the Good Manufacturing Practice (GMP) field.

The company will showcase its Custom GMP Cell Culture Media Services tailored for clinical applications and further manufacturing in the cell-based therapy industry at the 32nd ESGCT Congress in Seville, Spain, scheduled for October 7–10.

These services aim to bridge the gap between research and clinical application, offering Excipient GMP-grade cell culture media manufacturing and expert guidance through the entire research-to-commercialisation journey.

“We noticed an increasing demand for advanced cell culture media in regenerative medicine and cell-based therapy, and we are thrilled to introduce our GMP cell culture medium service portfolio to the life science community at the ESGCT Congress,” said Dr. Irma Börcsök, CEO of PromoCell.

Dr. Lucía Cespón, GMP Business Unit Lead at PromoCell, added, “This launch marks a major milestone for our team. We’ve worked closely with our clients in clinical applications to ensure that both our Custom GMP Cell Culture Media Services and our advanced cell culture media product portfolio ‘PromoExQ’ ensure the precision, flexibility, and compliance that modern translational research demands.”